Healthcare
Advisory
Sweden
2024
M&A Advisory
M&A Advisory Firm
Industry:
Healthcare
Location:
Sweden
Year:
2024
Investment:
$75.0M
Full Credential Description
Calliditas Therapeutics AB. Sweden. Announced Date 7/15/2021. Closed Date 7/15/2021. $75m. Calliditas secures $75 million term loan facility. Industry: Calliditas Therapeutics AB is a biopharmaceutical company focused on developing treatments for rare kidney diseases.
Measurable Results
$75.0M